Stay updated on Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page
- CheckyesterdayChange DetectedAdded the recruitment status 'No longer looking for participants' and updated the version history to include 'Revision: v3.6.0' while removing 'Revision: v3.5.5'.SummaryDifference0.2%

- Check8 days agoChange DetectedThe footer now displays Revision: v3.5.5 instead of v3.5.4, signaling a new release of the ClinicalTrials.gov interface. This update appears to be a minor site maintenance change and does not alter study data or the visible content of the study record.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new version entry (Version 40) dated 2026-05-15 adds updates to Study Status and Contacts/Locations. A matching addition dated 2026-05-18 is recorded, and the entry dated 2026-01-27 was removed.SummaryDifference0.3%

- Check29 days agoChange DetectedA new revision entry 'Revision: v3.5.4' has been added and the previous 'Revision: v3.5.3' removed, indicating an updated platform build. This update appears to be an internal software version change rather than a substantive modification to the study record.SummaryDifference0.1%

- Check50 days agoChange DetectedUpdates the ClinicalTrials.gov page’s displayed site software/revision version from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page.